Life Sciences

We work with life sciences organizations to improve innovation performance that delivers sustained results and bottom-line growth.

We partner with clients to implement innovation capabilities throughout the development lifecycle in order to deliver commercially successful drugs, devices, products and services that meet today’s evolving healthcare needs. We do this by developing and operationalizing strategies, organizational structure and processes; aligning them with regulatory requirements; and enabling with technology.

Industry Segments

  • Biotechnology
  • Combination Products
  • In Vitro Diagnostics
  • Medical Device
  • Nutraceuticals
  • Pharmaceuticals

Request More Information

White Paper Beyond Compliance: Medical Device Product Development

Kalypso has spent the last several years exploring how leading medical device companies - from startups to multibillion dollar enterprises - are balancing new product development with compliance requirements. Finding the right balance between what…
Read More

Article PLM – The Great Missed Opportunity for Life Sciences

PLM can help life sciences companies streamline processes and turn innovative ideas into high-value products, but while some pioneers understand the transformational opportunity, most still struggle to achieve it. Here's one key reason.
Read More

Article Innovation Enablement

Innovation is fun, but it can also be hard to find the time and data to do it well. PLM gives innovators time back to innovate, data to feed ideas, an innovation framework for support, and the ability to leverage past ideas for future work.
Read More

White Paper Medical Device Industry Playbook

The challenging macroeconomic business and regulatory climate is wreaking havoc on the medical device industry. Despite the challenges, manufacturers must design and implement effective, profitable innovation engines to capitalize on market…
Read More

White Paper Driving Innovation in BioPharma: From Discovery to Delivery with Product Lifecycle Management

Innovation in the biopharma industry is not going to get any easier, or any less complex. Adopting an entire lifecycle perspective to innovation will benefit the measures that matter the most – truly innovative products that generate real health…
Read More

White Paper Driving Compliance in Biopharma: Managing Product Data through Change Control

Managing biopharmaceutical products through their lifecycle is complex. It's compounded by constantly evolving scientific and regulatory environments, as well as frequent product changes. If you are using informal, non-standard processes to manage…
Read More

White Paper Driving Innovation in BioPharma: Harnessing the Value of a Single, Compliant Product Record

Global biopharma organizations are operating in an increasingly complex regulatory compliance environment with squeezed development budgets to bring more products to more markets. This white paper explores how product lifecycle management…
Read More

White Paper New eBook - FDA Unique Device Identification (UDI) System: Readiness and Beyond

On September 24, 2013 the final FDA rule for UDI took effect in the US. Medical Device manufacturers have one year to prepare. This eBook will help you assess your readiness and get started on your plan.
Read More

Chris Kay

Chris Kay

Life Sciences

Noel Sobelman

Noel Sobelman

Life Sciences

Scott Gibbard

Scott Gibbard

Pharmaceuticals & Biotechnology

Mick Broekhof

Mick Broekhof

Life Sciences Europe